New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33 percent when the coronavirus swept across Europe.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200616135754.htm
No comments:
Post a Comment